The Board may appoint an Executive Committee of the Board to serve at the pleasure of the Board, to consist of such Trustees as the Board may from time to time designate, but not less than three, and including in all events the President who shall be the Chairman of the Executive Committee, the Secretary and Treasurer. During the intervals between the meetings of the Board, the Executive Committee shall possess and exercise all the powers of the Board in the management and direction of the business and affairs of the Society; provided, however, that it shall have no power or authority with respect to amending the Certificate of Incorporation, adopting an agreement of merger or consolidation, recommending to the Members the sale, lease or exchange of any property and assets, recommending to the Members a dissolution of the Society or a revocation of a dissolution, or amending the by-laws of the Society.
The President shall appoint an Organizing Committee of Members to make arrangements for each Meeting of the Society. The Committee will have such authority as may be specifically given it by the Board of Trustees.
The Board of Trustees, after authorizing the President to sign a contract for an international or regional meeting of the Society, will appoint a Meeting Committee of the Members. The President will chair this committee and at least two Trustee Members and the Secretary must serve on this Committee. The responsibility of this Committee will be defined by the President in writing and must be approved by two-thirds majority of the Board of Trustees. The local sponsors must be represented by two or more scientists working on hyaluronan research in the selected country. The local organizational sponsor shall also be represented on thisCommittee. The Meeting Committee will be responsible for the compilation, editing and printing of the Abstract Book in the style established by the Society. The Proceedings containing the full text of lectures, posters or other forms of presentations will be compiled, edited and placed on the Internet site of the Society as soon as possible after the meeting. The Proceedings must be published also in printed form. The preparation and publication of the Proceedings will be the primary responsibility of the Meeting Committee or its subcommittee appointed by the President.
The objective of the Nomenclature Committee is to prepare for the Board, for approval, a system of nomenclature to characterize the polydisperse molecular population of hyaluronan for practical applications in science and industry. They shall include in the system the various cross-linked and otherwise modified forms of hyaluronan.
It is understood that the Committee’s members can invite any other member of ISHAS to join their deliberation.
The President shall appoint a three-member Nominating Committee from the currently serving Trustees for approval by two-thirds majority vote by Board of Trustees in every year. The President and the Secretary are ex-officio members of the Committee.
The Nominating Committee must evaluate the nomination of each individual to be a Member, Officer or a Trustee and make a recommendation to the President in detail as to whether or not the proposed Member or Trustee fulfills the requirements for election as a Member, officer or Trustee.